Plasma pTau217 may detect initial buildup of AD-related brain changes before they can be detected by current ‘gold standard’ ...

(Kaboompics.com/Pexels/Canva) A blood test shows significant promise for predicting the earliest stages of Alzheimer's ...

A new study​ finds that a simple blood test could predict Alzheimer's disease long before symptoms appear.

By Dennis Thompson HealthDay ReporterWEDNESDAY, April 15, 2026 (HealthDay News) — A blood test can predict Alzheimer’s ...

Findings suggest the test can reduce the need for PET imaging in some patients with mild cognitive decline to enable therapeutic focus on non-Alzheimer's disease causes, broadening access to quality ...

Findings showed 91.7% of patients with positive results using Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio test had amyloid plaques based on PET scan or CSF test results. The Food and Drug ...

Can a blood test predict Alzheimer’s? New research shows the pTau217 biomarker detects amyloid accumulation and cognitive ...

WASHINGTON — New blood tests could help doctors diagnose Alzheimer’s disease faster and more accurately, researchers reported Sunday — but some appear to work far better than others. Subscribe to read ...

Panelists discuss how managed care organizations can improve Alzheimer diagnostic test access while navigating complex coverage challenges for amyloid-targeting therapies across traditional Medicare ...

A newly published Cochrane systematic review examining amyloid-beta-targeting monoclonal antibodies in Alzheimer's disease ...

Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. Jerry Klauer, an Alzheimer's patient who received a ...

A study suggests that a blood test measuring the biomarker pTau217 can detect early signs of Alzheimer’s disease years before ...